|
|
|
|
Vol. 12, Issue 10, 2975-2986, October 2001
1 Integrin Function
through Interactions with Integrin
3
1


and
*Respiratory Division, Brigham and Women's Hospital, Harvard
Medical School, Boston, Massachusetts 02115; The urokinase receptor (uPAR) is linked to cellular migration
through its capacity to promote pericellular proteolysis, regulate integrin function, and mediate cell signaling in response to
urokinase (uPA) binding. The mechanisms for these activities
remain incompletely defined, although uPAR was recently identified as a
cis-acting ligand for the
Department
of Physiological Chemistry, University of Münster, 48149 Münster, Germany;
Department of Medicine,
Children's Hospital, and Department of Pediatrics, Harvard Medical
School, Boston, Massachusetts 02115; and §Pulmonary and
Critical Care Division, University of California at San Francisco, San
Francisco, California 94143.
2 integrin
CD11b/CD18 (Mac-1). Here we show that a major
1 integrin
partner for uPAR/uPA signaling is
3. In uPAR-transfected 293 cells
uPAR complexed (>90%) with
3
1 and antibodies to
3 blocked
uPAR-dependent vitronectin (Vn) adhesion. Soluble uPAR bound to
recombinant
3
1 in a uPA-dependent manner
(Kd < 20 nM) and binding was blocked
by a 17-mer
3
1 integrin peptide (
325) homologous to
the CD11b uPAR-binding site. uPAR colocalized with
3
1 in
MDA-MB-231 cells and uPA (1 nM) enhanced spreading and focal adhesion
kinase phosphorylation on fibronectin (Fn) or collagen type I
(Col) in a pertussis toxin- and
325-sensitive manner. A critical
role of
3
1 in uPA signaling was verified by studies of epithelial
cells from
3-deficient mice. Thus, uPAR preferentially complexes
with
3
1, promoting direct (Vn) and indirect (Fn, Col) pathways of
cell adhesion, the latter a heterotrimeric G protein-dependent mechanism of signaling between
3
1 and other
1 integrins.
Corresponding author: E-mail address:
halchap{at}itsa.ucsf.edu.
This article has been cited by other articles:
![]() |
T. Hillig, L. H. Engelholm, S. Ingvarsen, D. H. Madsen, H. Gardsvoll, J. K. Larsen, M. Ploug, K. Dano, L. Kjoller, and N. Behrendt A Composite Role of Vitronectin and Urokinase in the Modulation of Cell Morphology upon Expression of the Urokinase Receptor J. Biol. Chem., May 30, 2008; 283(22): 15217 - 15223. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Versteeg, F. Schaffner, M. Kerver, H. H. Petersen, J. Ahamed, B. Felding-Habermann, Y. Takada, B. M. Mueller, and W. Ruf Inhibition of tissue factor signaling suppresses tumor growth Blood, January 1, 2008; 111(1): 190 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Elia, E. Cassol, N. Sidenius, F. Blasi, A. Castagna, G. Poli, and M. Alfano Inhibition of HIV replication by the plasminogen activator is dependent on vitronectin-mediated cell adhesion J. Leukoc. Biol., November 1, 2007; 82(5): 1212 - 1220. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shetty, T. Velusamy, S. Idell, P. Shetty, A. P. Mazar, Y. P. Bhandary, and R. S. Shetty Regulation of Urokinase Receptor Expression by p53: Novel Role in Stabilization of uPAR mRNA Mol. Cell. Biol., August 15, 2007; 27(16): 5607 - 5618. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Lester, M. Jo, V. Montel, S. Takimoto, and S. L. Gonias uPAR induces epithelial mesenchymal transition in hypoxic breast cancer cells J. Cell Biol., July 24, 2007; 178(3): 425 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Madsen, G. M. S. Ferraris, A. Andolfo, O. Cunningham, and N. Sidenius uPAR-induced cell adhesion and migration: vitronectin provides the key J. Cell Biol., June 21, 2007; 177(5): 927 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. He, X.-d. Liu, Z.-y. Chen, J. Zhu, Y. Xiong, K. Li, J.-h. Dong, and X. Li Interaction between Cancer Cells and Stromal Fibroblasts Is Required for Activation of the uPAR-uPA-MMP-2 Cascade in Pancreatic Cancer Metastasis Clin. Cancer Res., June 1, 2007; 13(11): 3115 - 3124. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wei, C.-H. Tang, Y. Kim, L. Robillard, F. Zhang, M. C. Kugler, and H. A. Chapman Urokinase Receptors Are Required for {alpha}5beta1 Integrin-mediated Signaling in Tumor Cells J. Biol. Chem., February 9, 2007; 282(6): 3929 - 3939. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stefanidakis and E. Koivunen Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression Blood, September 1, 2006; 108(5): 1441 - 1450. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bujo and Y. Saito Modulation of Smooth Muscle Cell Migration by Members of the Low-Density Lipoprotein Receptor Family Arterioscler. Thromb. Vasc. Biol., June 1, 2006; 26(6): 1246 - 1252. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chaurasia, J. A. Aguirre-Ghiso, O. D. Liang, H. Gardsvoll, M. Ploug, and L. Ossowski A Region in Urokinase Plasminogen Receptor Domain III Controlling a Functional Association with {alpha}5beta1 Integrin and Tumor Growth J. Biol. Chem., May 26, 2006; 281(21): 14852 - 14863. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ghosh, J. J. Johnson, R. Sen, S. Mukhopadhyay, Y. Liu, F. Zhang, Y. Wei, H. A. Chapman, and M. S. Stack Functional Relevance of Urinary-type Plasminogen Activator Receptor-{alpha}3beta1 Integrin Association in Proteinase Regulatory Pathways J. Biol. Chem., May 12, 2006; 281(19): 13021 - 13029. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Monaghan-Benson and P. J. McKeown-Longo Urokinase-type Plasminogen Activator Receptor Regulates a Novel Pathway of Fibronectin Matrix Assembly Requiring Src-dependent Transactivation of Epidermal Growth Factor Receptor J. Biol. Chem., April 7, 2006; 281(14): 9450 - 9459. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Mazzieri, S. D'Alessio, R. K. Kenmoe, L. Ossowski, and F. Blasi An Uncleavable uPAR Mutant Allows Dissection of Signaling Pathways in uPA-dependent Cell Migration Mol. Biol. Cell, January 1, 2006; 17(1): 367 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Carrio, G. Arderiu, C. Myers, and N. J. Boudreau Homeobox D10 Induces Phenotypic Reversion of Breast Tumor Cells in a Three-Dimensional Culture Model Cancer Res., August 15, 2005; 65(16): 7177 - 7185. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Degryse, M. Resnati, R.-P. Czekay, D. J. Loskutoff, and F. Blasi Domain 2 of the Urokinase Receptor Contains an Integrin-interacting Epitope with Intrinsic Signaling Activity: GENERATION OF A NEW INTEGRIN INHIBITOR J. Biol. Chem., July 1, 2005; 280(26): 24792 - 24803. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gargiulo, I. Longanesi-Cattani, K. Bifulco, P. Franco, R. Raiola, P. Campiglia, P. Grieco, G. Peluso, M. P. Stoppelli, and M. V. Carriero Cross-talk between fMLP and Vitronectin Receptors Triggered by Urokinase Receptor-derived SRSRY Peptide J. Biol. Chem., July 1, 2005; 280(26): 25225 - 25232. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bass, F. Werner, E. Odintsova, T. Sugiura, F. Berditchevski, and V. Ellis Regulation of Urokinase Receptor Proteolytic Function by the Tetraspanin CD82 J. Biol. Chem., April 15, 2005; 280(15): 14811 - 14818. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wei, R.-P. Czekay, L. Robillard, M. C. Kugler, F. Zhang, K. K. Kim, J.-p. Xiong, M. J. Humphries, and H. A. Chapman Regulation of {alpha}5{beta}1 integrin conformation and function by urokinase receptor binding J. Cell Biol., January 31, 2005; 168(3): 501 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-P. Czekay and D. J. Loskutoff Unexpected Role of Plasminogen Activator Inhibitor 1 in Cell Adhesion and Detachment Experimental Biology and Medicine, December 1, 2004; 229(11): 1090 - 1096. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dorfleutner, E. Hintermann, T. Tarui, Y. Takada, and W. Ruf Cross-talk of Integrin {alpha}3{beta}1 and Tissue Factor in Cell Migration Mol. Biol. Cell, October 1, 2004; 15(10): 4416 - 4425. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Reiser, J. Oh, I. Shirato, K. Asanuma, A. Hug, T. M. Mundel, K. Honey, K. Ishidoh, E. Kominami, J. A. Kreidberg, et al. Podocyte Migration during Nephrotic Syndrome Requires a Coordinated Interplay between Cathepsin L and {alpha}3 Integrin J. Biol. Chem., August 13, 2004; 279(33): 34827 - 34832. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mayasundari, N. A. Whittemore, E. H. Serpersu, and C. B. Peterson The Solution Structure of the N-terminal Domain of Human Vitronectin: PROXIMAL SITES THAT REGULATE FIBRINOLYSIS AND CELL MIGRATION J. Biol. Chem., July 9, 2004; 279(28): 29359 - 29366. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Cao, Y.-L. Guo, and R. W. Colman Urokinase-Type Plasminogen Activator Receptor Is Involved in Mediating the Apoptotic Effect of Cleaved High Molecular Weight Kininogen in Human Endothelial Cells Circ. Res., May 14, 2004; 94(9): 1227 - 1234. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Brown, T. M. Yang, T. Zaitsevskaia, Y. Xia, C. A. Dunn, R. O. Sigle, B. Knudsen, and W. G. Carter Adhesion or Plasmin Regulates Tyrosine Phosphorylation of a Novel Membrane Glycoprotein p80/gp140/CUB Domain-containing Protein 1 in Epithelia J. Biol. Chem., April 9, 2004; 279(15): 14772 - 14783. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. A. DeClerck, A. M. Mercurio, M. S. Stack, H. A. Chapman, M. M. Zutter, R. J. Muschel, A. Raz, L. M. Matrisian, B. F. Sloane, A. Noel, et al. Proteases, Extracellular Matrix, and Cancer: A Workshop of the Path B Study Section Am. J. Pathol., April 1, 2004; 164(4): 1131 - 1139. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, W. Fu, J. H. Im, Z. Zhou, S. A. Santoro, V. Iyer, C. M. DiPersio, Q.-C. Yu, V. Quaranta, A. Al-Mehdi, et al. Tumor cell {alpha}3{beta}1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis J. Cell Biol., March 15, 2004; 164(6): 935 - 941. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kunneken, G. Pohlentz, A. Schmidt-Hederich, U. Odenthal, N. Smyth, J. Peter-Katalinic, P. Bruckner, and J. A. Eble Recombinant Human Laminin-5 Domains: EFFECTS OF HETEROTRIMERIZATION, PROTEOLYTIC PROCESSING, AND N-GLYCOSYLATION ON {alpha}3{beta}1 INTEGRIN BINDING J. Biol. Chem., February 13, 2004; 279(7): 5184 - 5193. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Monaghan, V. Gueorguiev, C. Wilkins-Port, and P. J. McKeown-Longo The Receptor for Urokinase-type Plasminogen Activator Regulates Fibronectin Matrix Assembly in Human Skin Fibroblasts J. Biol. Chem., January 9, 2004; 279(2): 1400 - 1407. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jo, K. S. Thomas, L. Wu, and S. L. Gonias Soluble Urokinase-type Plasminogen Activator Receptor Inhibits Cancer Cell Growth and Invasion by Direct Urokinase-independent Effects on Cell Signaling J. Biol. Chem., November 21, 2003; 278(47): 46692 - 46698. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhang, C. C. Tom, M. C. Kugler, T.-T. Ching, J. A. Kreidberg, Y. Wei, and H. A. Chapman Distinct ligand binding sites in integrin {alpha}3{beta}1 regulate matrix adhesion and cell-cell contact J. Cell Biol., October 13, 2003; 163(1): 177 - 188. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tarui, N. Andronicos, R.-P. Czekay, A. P. Mazar, K. Bdeir, G. C. Parry, A. Kuo, D. J. Loskutoff, D. B. Cines, and Y. Takada Critical Role of Integrin {alpha}5{beta}1 in Urokinase (uPA)/Urokinase Receptor (uPAR, CD87) Signaling J. Biol. Chem., August 8, 2003; 278(32): 29863 - 29872. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Feldman, V. I. Sementchenko, M. Gayed, M. M. Fraig, and D. K. Watson Pdef Expression in Human Breast Cancer Is Correlated with Invasive Potential and Altered Gene Expression Cancer Res., August 1, 2003; 63(15): 4626 - 4631. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Aguirre-Ghiso, Y. Estrada, D. Liu, and L. Ossowski ERKMAPK Activity as a Determinant of Tumor Growth and Dormancy; Regulation by p38SAPK Cancer Res., April 1, 2003; 63(7): 1684 - 1695. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.-P. Czekay, K. Aertgeerts, S. A. Curriden, and D. J. Loskutoff Plasminogen activator inhibitor-1 detaches cells from extracellular matrices by inactivating integrins J. Cell Biol., March 3, 2003; 160(5): 781 - 791. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Palmieri, S. Poggi, V. Ulivi, G. Casartelli, and P. Manduca Pro-collagen I COOH-terminal Trimer Induces Directional Migration and Metalloproteinases in Breast Cancer Cells J. Biol. Chem., January 31, 2003; 278(6): 3639 - 3647. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jo, K. S. Thomas, D. M. O'Donnell, and S. L. Gonias Epidermal Growth Factor Receptor-dependent and -independent Cell-signaling Pathways Originating from the Urokinase Receptor J. Biol. Chem., January 10, 2003; 278(3): 1642 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Montuori, M. V. Carriero, S. Salzano, G. Rossi, and P. Ragno The Cleavage of the Urokinase Receptor Regulates Its Multiple Functions J. Biol. Chem., November 27, 2002; 277(49): 46932 - 46939. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Post, C. Gass, S. Rice, D. Nikolic, H. Crump, and G. R. Post Class A scavenger receptors mediate cell adhesion via activation of Gi/o and formation of focal adhesion complexes J. Lipid Res., November 1, 2002; 43(11): 1829 - 1836. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Palmieri, J. W. Lee, R. L. Juliano, and F. C. Church Plasminogen Activator Inhibitor-1 and -3 Increase Cell Adhesion and Motility of MDA-MB-435 Breast Cancer Cells J. Biol. Chem., October 18, 2002; 277(43): 40950 - 40957. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Alfano, N. Sidenius, B. Panzeri, F. Blasi, and G. Poli Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication PNAS, June 25, 2002; 99(13): 8862 - 8867. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Resnati, I. Pallavicini, J. M. Wang, J. Oppenheim, C. N. Serhan, M. Romano, and F. Blasi The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R PNAS, January 24, 2002; (2002) 22652999. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Resnati, I. Pallavicini, J. M. Wang, J. Oppenheim, C. N. Serhan, M. Romano, and F. Blasi The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R PNAS, February 5, 2002; 99(3): 1359 - 1364. [Abstract] [Full Text] [PDF] |
||||